Market Place
Sourcing Support
Type 2 diabetes drug Rosiglitazone increases risk of heart problems
13 Feb 2020 //
PHARMAFILE
New study adds to evidence of diabetes drug link to heart problems
06 Feb 2020 //
PRESS RELEASE
The Most Wonderful Mistake the FDA Ever Made
07 Dec 2018 //
MEDPAGE TODAY
New Diabetes Drugs Will Still Require CV Outcomes Trials
06 Nov 2018 //
FORBES
FDA Experts May Reconsider Diabetes Drug Safety Rules
26 Oct 2018 //
FORBES
Novel Diabetes Drugs Sensitize Cancer Cells to Chemotherapy Agents
02 Jan 2018 //
DDDMAG
Rare Diseases Patients Need More Than Miracles And Trumpcare
18 Mar 2017 //
FORBES
GlaxoSmithKline Must Face Insurers’ Drug Fraud Claims
18 Nov 2016 //
BNA
AZ Taps 3SBio to Help Drive Sales of Diabetes Meds Byetta, Bydureon in China
14 Oct 2016 //
FIERCE PHARMA
SCOTUS silence means GSK really does have to face claims
08 Jun 2016 //
FIERCE PHARMA
Supreme Court says Glaxo must face racketeering lawsuits over a diabetes pill
06 Jun 2016 //
STAT
Teva Secures Final FDA Approval and Market Exclusivity for Generic Avandaryl
10 Apr 2016 //
TWOFOUR INSIGHT
NEJM study finds Actos holds off repeat strokes in insulin-resistant patients
18 Feb 2016 //
FIERCE PHARMA
FDA Lifts Restriction On Rosiglitazone
16 Dec 2015 //
FDA
Lyxumia`s may help Sanofi`s case for approval,but won`t score against SGLT2s
03 Dec 2015 //
FIERCE PHARMA
Could Common Diabetes Drugs Help Fight Leukemia?
02 Sep 2015 //
WEBB MD
Are Diabetes CV Trials Worth It? Some Say No
13 Jun 2015 //
MEDPAGE TODAY
Sanofi`s Diabetes Franchise One Step Closer To U.S. Lyxumia Launch
20 Mar 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.